Bacil Pharma Ltd. BSE: 524516

Download real time

38.04 1.75 (4.82%)

39.19% Fall from 52W High

6,717

BSE Volume

BSE 19 Sep, 2025 3:31 PM (IST)

Bacil Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bacil Pharma Ltd. on BSE

Search Inside the pdf :

Bacil Pharma Ltd.

05 Sep 2025

38.04

4.82%

Corp. Action

Bacil Pharma Ltd - 524516 - Book Closure For The Purpose Of Annual General Meeting

BSE India

Book Closure for the Purpose of Annual General Meeting

Bacil Pharma Ltd.

05 Sep 2025

38.04

4.82%

Corp. Note

Bacil Pharma Ltd - 524516 - Reg. 34 (1) Annual Report.

BSE India

38th Annual Report of the Company

Bacil Pharma Ltd.

05 Sep 2025

38.04

4.82%

AGM

Bacil Pharma Ltd - 524516 - Notice Of 38Th Annual General Meeting Of The Company

BSE India

Notice of 38th Annual General Meeting of the Company

Bacil Pharma Ltd.

05 Sep 2025

38.04

4.82%

Board Meeting

Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Outcome of Board Meeting held on 05th September, 2025

Bacil Pharma Ltd.

04 Sep 2025

38.04

4.82%

Company Update

Bacil Pharma Ltd - 524516 - INTIMATION OF RECEIPT OF REQUEST FOR RECLASSIFICATION OF THE 'PROMOTER' …

BSE India

Intimation of Receipt of Request for Reclassifiaction of the Promoter in accordance with Regulation 31A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Bacil Pharma Ltd.

02 Sep 2025

38.04

4.82%

Board Meeting

Bacil Pharma Ltd - 524516 - Board Meeting Intimation for We Hereby Notify You That A …

BSE India

Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2025 ,inter alia, to consider and approve To discuss and approve the following matters: Discussion on Notice for 38th Annual General Meeting for the Company. Discussion on Director Report of the Company for the Financial Year 2024-2025. Discussion to Fix Date, Place and Timing of 38th Annual General Meeting of the Company Discussion on matter related to Loan to Equity shares of the Company. Any other business with the permission of Chairperson.

Bacil Pharma Ltd.

27 Aug 2025

38.04

4.82%

Company Update

Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Revised Outcome Of Board Meeting Held …

BSE India

Revised outcome of Board Meeting held on 25th August 2025. The earlier revised outcome uploaded has incorrect w.e.f date of appointment of statutory auditor. The correct w.e.f date is 25th August,2025

Bacil Pharma Ltd.

27 Aug 2025

38.04

4.82%

Company Update

Bacil Pharma Ltd - 524516 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

BSE India

Approval for Appointment of M/s Sarang Shivajirao Chavan & Associates as the Statutory Auditor of the Company.

Bacil Pharma Ltd.

27 Aug 2025

38.04

4.82%

Company Update

Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Revised Outcome Of Board Meeting Held …

BSE India

Revised outcome of Board Meeting on 25th August 2025

Bacil Pharma Ltd.

25 Aug 2025

38.04

4.82%

Company Update

Bacil Pharma Ltd - 524516 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

BSE India

Announcement under Regulation 30 (LODR) - Appointment of Statutory Auditor M/s Sarang Shivajirao Chavan & Associates

Is Bacil Pharma Ltd. worth buying?

10 Votes:

Buy 30.0%

Sell 40.0%

Hold 30.0%